FDA
approval
· 2025-03-28
FDA Approved: SUMATRIPTAN — Supplemental Application (Rising Pharma Holdings, Inc.)
Summary
The FDA approved a supplemental application for Sumatriptan submitted by Rising Pharma Holdings, Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for SUMATRIPTAN (SUMATRIPTAN)